Edit

Panakes Partners

http://www.panakes.it
Last activity: 17.07.2024
Probably Closed
Invests in categories: MedTechHardwareTechnologyProductPlatformITHealthTechDevelopmentRoboticsLife
News
37
Portfolio
18
Persons
1
Mentions
15
Location: Italy, Lombardy, Milan
Employees: 11-50
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A

Portfolio 18

DateNameWebsiteTotal RaisedLocation
29.11.2023Nouscom AGnouscom.com$135.77MSwitzerlan...
26.10.2023Approximaapproximamedical.com-Italy, Lom...
02.08.2023Allotexallotex.com-United Sta...
02.08.2023EBAMedeba-med.com$16.94MSwitzerlan...
01.05.2023Complement...complementtx.com$84.66MUnited Kin...
11.08.2022Vivasure M...vivasuremedical.com$73.84MIreland, G...
11.08.2022SamanTree ...samantree.com$16.43MUnited Sta...
10.04.2022Neuromod D...neuromoddevices.com$60.56MIreland, D...
21.12.2018DIADEM DXdiademdx.com$12.75MItaly, Lom...
-Cartheracarthera.eu$64.82MFrance, Il...
Show more

Persons 1

DateFirst NameLast NameTitleLinkedIn
-MichelaBarcellaNetwork an...linkedin.c...

News 37

DateTitleDescription
27.09.2021PANAKÈS PARTNERS APPOINTS DR. ROB WOODMAN AS PARTNER TO LEAD BIOTECH INVESTMENTPANAKÈS PARTNERS APPOINTS DR. ROB WOODMAN AS PARTNER TO LEAD BIOTECH INVESTMENT DR. ROB WOODMAN BRINGS 15 YEARS OF EXPERIENCE IN LIFE SCIENCE INVESTING AND A TRACK RECORD OF SUCCESS IN BOTH INSTITUTIONAL AND CORPORATE VENTURE CAPITAL • Pana...
28.07.2021Panakes Partners Announces the hiring of Dr. Marco Sardina as Scientific Partner and Dr. Andrea Ballerini as AssociatePanakes Partners SGR, a leading Venture Capital investor creating and building the next generation of innovative European Life Science companies, announced today that Dr. Marco Sardina has joined the team as Scientific Partner and Dr. Andre...
20.07.2021PANAKÈS PARTNERS ANNOUNCES THE FIRST CLOSING OF ITS NEW “PURPLE” GLOBAL BIOTECH/ MEDTECHPANAKÈS PARTNERS ANNOUNCES THE FIRST CLOSING OF ITS NEW “PURPLE” GLOBAL BIOTECH/ MEDTECH FUND AT €150 MILLION ($180 MILLION) • Panakès will use the successful closing of its second Fund to extend its investment activity to biotech, while ma...
01.07.2021Salvia BioElectronics B.V. ("Salvia"), a neurostimulation platform company targeting chronic migraine, announces today the appointmentSalvia BioElectronics B.V. ("Salvia"), a neurostimulation platform company targeting chronic migraine, announces today the appointment of Dr Alan Levy as Chairman of the Board of Directors. Dr Levy has 40 years of senior operation...
09.06.2021CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces preclinical resultsCarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces preclinical results in the testing of the combination of SonoCloud® technology with immunotherapies. ...
04.06.2021Endostart,startup toscana che ha sviluppato una piattaforma endoscopica che mira alle colonscopie incomplete, già certificata ISO13485Endostart, startup toscana che ha sviluppato una piattaforma endoscopica che mira alle colonscopie incomplete, già certificata ISO13485, ha annunciato di aver chiuso, insieme a nuovi e già presenti investitori, un aumento di capitale di €8....
13.05.2021Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD)Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD), today announced new data showing that its AlzoSure® prognostic biomarker test can accurately predict progression to Alzheimer'...
06.04.2021Vivasure Medical®, a company pioneering fully absorbable solutions for large hole percutaneous vessel closure, today announced Andrew Glass has assumed the role of chief executiveVivasure Medical®, a company pioneering fully absorbable solutions for large hole percutaneous vessel closure, today announced Andrew Glass has assumed the role of chief executive officer. Founder and former CEO Ger Brett will transition to...
12.03.2021Panakès Partners sgr, società di venture capital specializzata in investimenti in aziende innovative nel settore delle scienze della vita, ha nominato partner Barbara CastellanoPanakès Partners sgr, società di venture capital specializzata in investimenti in aziende innovative nel settore delle scienze della vita, ha nominato partner Barbara Castellano e assunto con la carica di direttore finanziario Lorenzo Giord...
12.02.2021Aileens Pharma, società di biotecnologia impegnata nella ricerca clinica, attiva nello sviluppo di trattamenti per le malattie della pelleAileens Pharma, società di biotecnologia impegnata nella ricerca clinica, attiva nello sviluppo di trattamenti per le malattie della pelle che colpiscono il microbioma cutaneo, ha annunciato la nomina di Mathieu Simon a presidente del Consi...
Show more

Mentions in press and media 15

DateTitleDescription
17.07.2024SamanTree Medical makes strategic changes after $14M round From biopsy taking to surgical diagnosis, tissue assessment is a key component to efficient and straightforward cancer treatment. However, obtaining high-resolution results promptly remains a major challenge. SamanTree’s Histolog Scanner i...
14.11.2023Nouscom raises CHF65 million in oversubscribed Series C financing round
28.06.2023EUR 14.35 million to advance cardiac radiation ablation therapy
11.05.2023Il mercato del Venture Capital ad aprile 2023Come è andato il mercato del Venture Capital ad aprile 2023? Facciamo insieme una carrellata delle startup, delle scaleup e dei round più interessanti. Purtroppo, i dati del primo trimestre 2023 confermano i trend negativi in Europa per gli...
04.10.2021Finanțări pentru startup-uri medicale europene prin fonduri de investiții de 1,7 miliarde EuroStartup-urile și firme mai dezvoltate, care inovează în medicină și alte științe ale vieții, au la dispoziție finanțări totale 1,7 miliarde de euro, prin 8 fonduri de investiții europene, susținute de UE și de mari companii, precum Google. ...
14.04.2020SwissDeCode selected by European Innovation Council for Covid-19 pitching event
14.04.2020SwissDeCode selected by European Innovation Council for Covid-19 pitching eventSwissDeCode developed DNAFoil technology, a portable, self-administered, on-site DNA detection kit, which combines both food safety and compliance with regulatory bodies in a single tool.
07.05.2019SamanTree Medical raises CHF 9.5m in Series A round
21.12.2018Diadem, an academic spin-off active in early Alzheimer diagnostic, raises €1,5 million in its A Round led by Panakes PartnersDiadem, an academic spin-off active in early Alzheimer diagnostic, raises €1,5 million in its A Round led by Panakes Partners Panakès Partners has led an investment round of ca. €1,5 million in Diadem an innovative startup based in Milan an...
25.07.2018Aileens Pharma Raises €3M in Series A FundingAileens Pharma S.r.l., a Milan, Italy-based developer of treatments to improve clinical outcomes in patients suffering from dermatological diseases, completed a €3M Series A financing. The round was led by Panakes Partners, alongside Invita...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In